journal article·2025-01

A Multi‐Functional Cascade Nanoreactor for Remodeling Tumor Microenvironment to Realize Mitochondria Dysfunction via ROS/Zn2+ Ions Overload

Longhai Jin, Shijie Zhou, Tianqi Zhang, Fengzhi Cui, Haijia Yu, Jianqiu Wang, Meng Wu, Yinghui Wang, Shuyan Song, Songtao Zhang, Hongjie Zhang, Jianhua Liu

Small· Volume 21· Issue 2
Publisher page

Abstract

Abstract Combining chemo/photodynamic therapy (CDT/PDT) to generate highly harmful reactive oxygen species and cause mitochondria dysfunction is considered a potential strategy to improve the efficiency of anticancer treatment. However, within tumor, the relatively deficient concentration of H2O2, hypoxic microenvironment, and overexpressed reduced glutathione (GSH) seriously suppress the efficacy of dynamic therapy. Herein, a multi‐functional cascade nanoreactor, bovine serum albumin modified ZnO2@CeO2‐ICG, is reported for remodeling tumor microenvironment (TME) to boost dynamic therapy and realize mitochondria dysfunction via reactive oxygen species (ROS) storm/Zn2+ ions overload. Within TME, ZnO2 decomposed into exogenous H2O2 and Zn2+ ion. The dual enzyme‐like CeO2 catalyzes the increased H2O2 into ·OH and oxygen molecules respectively, and then the oxygen molecules are translated into 1O2 by indocyanine green (ICG) under 808 nm light irradiation to boost PDT. The effective consumption of GSH through the reduction of Ce(IV) ions not only regenerates Ce(III) ions to enhance the efficiency of CDT but also efficaciously alleviates the elimination of ROS generated by dynamic therapy to further improve dynamic therapeutic efficiency. So the improved ROS level under remodeling TME and Zn2+ ions acutely lead to mitochondria dysfunction to boost the efficiency of antitumor treatment. Thus, developing functional nanoreactors that enable remodeling TME provides a potential strategy to enhance the efficiency of dynamic therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology The Second Hospital of Jilin University Changchun 130041 China

State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry (CIAC) Chinese Academy of Sciences(CAS) Changchun 130022 China

University of Science and Technology of China Hefei Anhui 230026 China

Department of Radiology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Jinan 250014 China

School of Basic Medical Sciences Guangzhou Medical University Guangzhou 511436 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jilin Province · Guangzhou Medical University · Jilin University

References (35)

Show source-provided references
1. 10.1021/acs.bioconjchem.9b0044810.1021/acs.bioconjchem.9b00448 ↗
2. 10.1002/advs.20210383610.1002/advs.202103836 ↗
3. 10.1016/j.nantod.2020.10085110.1016/j.nantod.2020.100851 ↗
4. 10.1111/cpr.1286510.1111/cpr.12865 ↗
5. 10.1016/j.cub.2020.06.08110.1016/j.cub.2020.06.081 ↗
6. Ma G. L. · Mil. Med. Res. · 2023 · 10 · 20
7. Xiong D. · Mil. Med. Res. · 2023 · 10 · 59
8. 10.1002/VIW.2020008910.1002/VIW.20200089 ↗
9. Hong W. L. · Mil. Med. Res. · 2024 · 11 · 59
10. 10.1016/j.nantod.2022.10175110.1016/j.nantod.2022.101751 ↗
11. 10.1016/j.cej.2020.12449410.1016/j.cej.2020.124494 ↗
12. 10.1039/D2TB02273G10.1039/D2TB02273G ↗
13. 10.1002/adfm.20210610610.1002/adfm.202106106 ↗
14. 10.1039/D3TB01802D10.1039/D3TB01802D ↗
15. 10.1002/adfm.20211339710.1002/adfm.202113397 ↗
16. 10.1002/adma.20200689210.1002/adma.202006892 ↗
17. 10.1021/acsnano.1c0312810.1021/acsnano.1c03128 ↗
18. 10.1016/j.cclet.2021.11.04810.1016/j.cclet.2021.11.048 ↗
19. 10.1002/advs.20210024110.1002/advs.202100241 ↗
20. 10.1016/j.jcis.2021.11.10710.1016/j.jcis.2021.11.107 ↗
21. 10.1039/D0BM00625D10.1039/D0BM00625D ↗
22. 10.1016/j.cej.2021.13148510.1016/j.cej.2021.131485 ↗
23. 10.1016/j.cej.2021.13443810.1016/j.cej.2021.134438 ↗
24. 10.1016/j.cej.2022.13993910.1016/j.cej.2022.139939 ↗
25. 10.1002/adfm.20221251010.1002/adfm.202212510 ↗
26. 10.1021/acsnano.5b0617510.1021/acsnano.5b06175 ↗
27. 10.1021/acs.nanolett.8b0272010.1021/acs.nanolett.8b02720 ↗
28. 10.1021/acsami.7b0681410.1021/acsami.7b06814 ↗
29. 10.1021/acs.nanolett.8b0317810.1021/acs.nanolett.8b03178 ↗
30. 10.1002/advs.20190213710.1002/advs.201902137 ↗
31. 10.1007/s13238-021-00881-410.1007/s13238-021-00881-4 ↗
32. 10.7150/thno.3983110.7150/thno.39831 ↗
33. 10.1016/j.ccr.2023.21553510.1016/j.ccr.2023.215535 ↗
34. 10.1093/nsr/nwab13910.1093/nsr/nwab139 ↗
35. 10.1002/adfm.20220922710.1002/adfm.202209227 ↗